Caption Management, LLC Myriad Genetics Inc Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$17.98 - $25.47 $688,634 - $975,501	38,300 New	38,300 $936,000
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $804,623 - $1.23 Million	57,845 New	57,845 $1.11 Million
Q2 2023 Aug 14, 2023	BUY	$17.56 - $23.76 $1.49 Million - $2.02 Million	85,017 New	85,017 $1.97 Million
Q2 2022 Aug 15, 2022	SELL	$16.45 - $25.88 $246,750 - $388,200	-15,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$22.67 - $28.01 $340,050 - $420,150	15,000 New	15,000 $378,000
Q2 2019 Aug 13, 2019	SELL	$22.67 - $35.0 $793,450 - $1.23 Million	-35,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$26.93 - $34.7 $942,550 - $1.21 Million	35,000 New	35,000 $1.16 Million

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.08B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.